ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

STAR completes enrollment.

July 30, 2004

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

HHS Says NIH Improperly Used Program For Scientists To Hire Administrators.

July 13, 2001

ACS Announces New Awards for Nurses

October 30, 1987

ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s

August 6, 1993